Αποτελέσματα Αναζήτησης
15 Ιουλ 2014 · Neuropsychiatric symptoms (NPS) such as depression, apathy, aggression, and psychosis are now recognized as core features of Alzheimer's disease (AD), and there is a general consensus that greater symptom severity is predictive of faster cognitive decline, loss of independence, and even shorter survival.
- Figure 1
Neuropsychiatric symptoms (NPS) such as depression, apathy,...
- Figure 1
6 Ιουν 2019 · Two meta-analyses indicated some efficacy regarding the use of Alzheimer's disease medications for the improvement of BPSD. One by Trinh et al. reported that cholinesterase inhibitors produced modest improvements in neuropsychiatric and functional outcomes, compared with placebo.
10 Ιαν 2022 · Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer’s disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine.
29 Δεκ 2023 · Neuropsychiatric or behavioral symptoms of dementia encompass a series of disorders, such as anxiety, depression, apathy, psychosis, and agitation, all commonly present in individuals living with dementia.
10 Ιαν 2022 · Alzheimer’s disease is associated with impairments in emotional communication including comprehension and production of facial emotional expressions, comprehension of affective prosody, and alexithymia.
16 Ιουλ 2021 · Many patients with Alzheimer’s disease (AD) are physically frail or have substantial functional impairments. There is growing evidence that such patients are at higher risk for medication-induced adverse events.
Antipsychotic drugs are often used for the treatment of behavioral and psychological symptoms of dementia (BPSD), especially psychosis and behavioral disturbances (e.g., aggression and...
